InvestSMART

Biome Australia Limited (ASX:BIO)

ALERT: Price-sensitive ASX Announcement for BIO
Current share price for BIO : $0.265 -0.01 (-3.64%)+
Release
12 May 2026 8:37AM
Price at Release
$0.275
Full Release
download
Summary
Biome Australia Limited announced the extension of its exclusive supply agreement with Probiotical SpA until 2028, maintaining existing commercial terms. This strategic partnership, vital for Biome’s supply chain, supports their international growth and aligns with their Australian manufacturing onshoring program. Blair Vega Norfolk highlights the continued collaboration's importance to Biome's expansion in markets like Australia, Canada, the UK, and New Zealand. Biome continues to innovate in live biotherapeutics and complementary medicines, supported by clinical research.
Key Points
  • Biome Australia Limited has extended its exclusive supply agreement with Probiotical SpA until 2028.
  • The agreement extends the previous supply agreement which was due to expire in June 2026.
  • Existing commercial terms of the agreement remain intact with the extension.
  • The partnership with Probiotical is part of Biome's broader supply chain strategy.
  • Biome's Australian manufacturing onshoring program continues to progress.
  • Blair Vega Norfolk, Managing Director of Biome, emphasizes the strategic importance of Probiotical.
  • Biome Australia focuses on innovative, evidence-based live biotherapeutics and complementary medicines.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.